Skip to main content

Illinois IGB

Adam Nelczyk

New therapeutic target identified for triple-negative breast cancer

August 26, 2022

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have discovered that the nuclear receptor TLX can potentially be used for therapeutic intervention.

August 26, 2022

Related Articles

Subscribe to Adam Nelczyk